{"title": "The top 10 drug launches since 2017", "author": "Angus Liu", "url": "https://www.fiercepharma.com/special-report/top-10-drug-launches-since-2017", "hostname": "fiercepharma.com", "description": "In a way, every drug is successful for the patients it has helped, be it for a common chronic illness, a prevalent type of cancer, or a rare disease affecting 1 in 10,000 people. But some drugs turn out more rewarding than others, financially speaking. After years of laborious drug R&D finally turn into a regulatory approval, biopharma companies look forward hopefully to a continuous and abundant flow of revenue to make the investment worthwhile. And it all starts with a successful launch. | After years of laborious drug R&D finally yield an approval, biopharma companies hope for a continuous and abundant flow of revenue to make the investment worthwhile. And it all starts with a successful launch. Here are the top 10 recent rollouts that have fulfilled those very hopes, at least so far.", "sitename": "FiercePharma", "date": "2020-05-18", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}